Targeted Cancer Therapy

Targeted Cancer Therapy is one of the chief means of medical treatment for Cancer. Targeted Therapy blocks the development of Cancer cells by interfering with Specific Targeted Molecules required for carcinogenesis and tumor growth rather than by simply interfering with all rapidly dividing cells. Targeted Cancer Therapies are likely to be more effective than older forms of treatments and less harmful to normal cells. Numerous Targeted Therapies are examples of immunotherapy using immune mechanisms for therapeutic purposes developed by the field of cancer immunology. So, as immunomodulators, they are one type of biological response modifiers.

 

  • FDA approved Targeted Therapies for Cancer
  • Monoclonal Antibody-conjugated Nanoparticles for Targeted Cancer Therapy
  • Types of targeted therapies: hormone therapies, signal transduction inhibitors, expression modulators, apoptosis inducers, angiogenesis inhibitors, toxin delivery molecules etc.
  • Molecular targeted therapies

Related Conference of Targeted Cancer Therapy

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Targeted Cancer Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in